Fusion promoter or fusion inhibitor?

ononuclear phagocytes can fuse to form osteoclasts or multinuclear giant cells. The latter are hallmarks of Crohn’s disease, granulomas, tumors, and fungal and HIV infections. Though the precise function of these syncytia remains unclear, Takeda et al. (page 945) now provide important new insights into phagocyte fusion, suggesting that the process may differ considerably from other types of cell fusion. Earlier work identified several cell surface proteins required for phagocyte fusion, but the authors focused on CD9 and CD81, transmembrane proteins in the tetraspanin family that promote the fusion of gametes, myoblasts, and virus-infected cells. Surprisingly, the expression of both proteins is elevated in mononuclear phagocytes cultured under normal conditions, but under fusogenic conditions CD9 and CD81 expression M